Alterations of the cyclin-dependent kinase inhibitor p19INK4D is rare in hematopoietic malignancies

Leukemia

Volumn 10, Issue 12, 1996, Pages 1897-1900

  Shiohara, M ^a   Spirin, K ^a   Said, J W ^b   Gombart, A F ^a   Nakamaki, T ^a   Takeuchi, S ^a   Hatta, Y ^a   Morosetti, R ^a   Tasaka, T ^a   Seriu, T ^c   Bartram, C ^c   Miller, C W ^a   Tomonaga, M ^d   Koeffler, H P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF ULM   (Germany)

^d NAGASAKI UNIVERSITY   (Japan)

Author keywords

CDKI; Deletion; Hematopoietic malignancy; p19INK4D; SSCP

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P21;

ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; AMINO TERMINAL SEQUENCE; ARTICLE; BURKITT LYMPHOMA; CHILDHOOD LEUKEMIA; CHRONIC MYELOID LEUKEMIA; GENE DELETION; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LEUKEMIA; LEUKEMIA CELL LINE; LYMPHOMA; LYMPHOMA CELL LINE; MAJOR CLINICAL STUDY; MOLECULAR CLONING; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; T CELL LEUKEMIA;

EID: 0030448905     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-816.
2. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler K, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825.
3. Polyak K, Lee M-H, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J. Cloning of p27 kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78: 59-66.
4. Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 1994; 78: 67-74.
5. KIP2, cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995; 9: 639-649.
6. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 1995; 9: 650-662.
7. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366: 704-707.
8. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson D. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994; 368: 753-756.
9. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-440.
10. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 1994; 371: 257-261.
11. Guan K-L, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, Matera AG, Xiong Y. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 1994; 8: 2939-2952.
12. INK4. Mol Cell Biol 1995; 15: 2682-2688.
13. Hirai H, Roussel MF, Kato J-Y, Ashmun R, Sherr CJ. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol 1995; 15: 2672-2681.
14. Spruck CH, Ganzalez-Zulueta M, Shibata A, Simoneau AR, Lin MF, Gonzalez F, Tsai YC, Jones PA. p16 gene in uncultured tumors. Nature 1994; 370: 183-184.
15. Caldas P, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994; 8: 27-32.
16. Schmidt EE, Ichimura K, Reifenberger G, Collins VP. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 1994; 54: 6321-6324.
17. INK4A and p18 genes in acute lymphoblastic leukemia (ALL) of childhood. Blood 1995; 86: 755-760.
18. Hatta Y, Hirama T, Carl WM, Yamada Y, Tomonaga M, Koeffler HP. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T cell leukemia. Blood 1995; 85: 2699-2704.
19. INK4B/MTS2 in pediatric acute lymphoblastic leukemia. Blood 1995; 85: 2321-2330.
20. Ogawa S, Hirano N, Sato N, Takahashi T, Hangaishi A, Tanaka K, Kurokawa M, Tanaka T, Mitani K, Yazaki Y, Hirai H. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. Blood 1994; 84: 2431-2435.
21. INK4B) display frequent homozygous deletions in primary cells from T but not from B cell lineage acute lympoblastic leukemias. Blood 1994; 84: 4038-4044.
22. Nakamaki T, Kawamata N, Scwaller J, Tobler A, Fey M, Pakkala S, Lee YY, Kim BK, Fukuchi K, Tsuruoka N, Kahan J, Miller CW, Koeffler HP. Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukemias. Br J Haematol 1995; 91: 139-149.
23. Ogawa S, Hangaishi A, Miyawaki S, Hirosawa S, Miura Y, Takeyama K, Kamada N, Ohtake S, Uike N, Shimazaki C, Toyama K, Hirano M, Mizoguchi K, Kobayashi Y, Furusawa S, Saito M, Nobuhiko E, Yazaki Y, Ueda R, Hirai H. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood 1995; 86: 1548-1556.
24. Quesnel B, Preudhomme C, Philippe N, Vanrumbeke M, Dermite S, Lai JL, Bauters F, Wattel E, Fenaux P. p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood 1995; 85: 657-663.
25. Dreyling MH, Bohlander SK, Le'Beau MM, Olopade OI. Cloned mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies. Blood 1995; 86: 1931-1938.
26. INK4 gene inactivation in acute lymphocytic leukemia. Blood 1995; 85: 3431-3436.
27. INK4B gene deletions in primary leukemias. Blood 1995; 86: 311-315.
28. Fizzotti M, Cimino G, Pisegna S, Alimena G, Quartatone C, Mandelli F, Pelicci PG, Lo Coco F. Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features. Blood 1995; 85: 2685-2690.
29. INK4B/MTS2 in human leukemias and lymphomas. Cancer Res 1995; 55: 1436-1440.
30. Stranks G, Height SE, Mitchell T, Jadayel D, Yuille MAR, De Lord C, Clutterbuck RD, Treleaven JG, Powles RL, Nacheva E, Oscier DG, Karpas A, Lenoir GM, Smith SD, Millar JL, Catovsky D, Dyer MJS. Deletions and rearrangement of CDKN2 in lymphoid malignancy. Blood 1995; 85: 893-901.
31. Ohnishi H, Kawamura M, Ida K, Sheng XM, Hanada R, Nobori T, Yamamori S, Hayashi Y. Homozygous deletions of p16/MTS1 gene are frequent but mutations are infrequent in childhood T cell acute lymphoblastic leukemia. Blood 1995; 86: 1269-1275.
32. Huret JL, Brizard A, Slater A, Charrin C, Bertheas MF, Guilhot F, Hahlen K, Kroes W, van Leeuwen E, School EV. Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyse of 48 patients - updated published cases and 16 new observations. Leukemia 1993; 7: 152-160.
33. Hayashi K. PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Meth Appl 1991; 1: 34-39.
34. Fenaux P, Jonveaux P, Quiquandaon I, Lai JL, Pignon JM, Loucheux-Lefebvre MH, Bauters F, Berger T, Kerckaert JP. p53 gene mutations in acute myeloid leukemia with 17p monosomy. Blood 1991; 78: 1652-1659.
35. KIP1 gene in non-Hodgkin's lymphomas and adult T cell leukemia/lymphoma. Blood 1995; 86: 1924-1930.
36. INK4B in non-Hodgkin's lymphomas. Blood 1995; 86: 1534-1539.
37. Shiohara M, El-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen D-L, Vogelstein B, Koeffler HP. Absence of WAF1 mutations in a variety of human malignancies. Blood 1994; 84: 3781-3784.